Aminobenzoic acids and derivatives
eMolecules 82956-11-4 | Nafamostat mesylate | Combi-Blocks, Inc. | MFCD00941430 | 539.580 | C21H25N5O8S2 | 98.000 | CS(O)(=O)=O.CS(O)(=O)=O.NC(=N)Nc1ccc(cc1)C(=O)Oc1ccc2cc(ccc2c1)C(N)=N | 1g | 586079372
Nafamostat mesylate | Combi-Blocks, Inc. | 82956-11-4 | MFCD00941430 | 539.580 | C21H25N5O8S2 | 98.000 | CS(O)(=O)=O.CS(O)(=O)=O.NC(=N)Nc1ccc(cc1)C(=O)Oc1ccc2cc(ccc2c1)C(N)=N | 1g | 586079372
Medchemexpress LLC Lazertinib (mesylate) | 2247995-37-3 | 99.85% | 650.75 | 1 ML
Lazertinib mesylate is a potent, selective, CNS-penetrant, orally available, and irreversible EGFR tyrosine kinase inhibitor. It shows high selectivity for activating (EGFRm) and T790M resistance mutations, inhibiting phosphorylation of EGFR, AKT, and ERK. This leads to apoptosis and suppression of tumor growth, making it suitable for the study of non-small cell lung cancer.
- Potent, selective, CNS-penetrant, orally available, and irreversible EGFR tyrosine kinase inhibitor.
- Shows high selectivity for activating (EGFRm) and T790M resistance mutations.
- Inhibits phosphorylation of EGFR, AKT, and ERK.
- Leads to apoptosis and suppression of tumor growth.
- Suitable for the study of non-small cell lung cancer.
Medchemexpress LLC Pritelivir mesylate | 1428333-96-3 | C19H22N4O6S3 | 50 MG
Pritelivir mesylate (BAY 57-1293 mesylate) is an inhibitor of the viral helicase-primase complex, demonstrating antiviral activity both in vitro and in animal models of herpes simplex virus (HSV) infection. It is active against HSV-1 and HSV-2 with an IC50 of 0.02 μM, making it the first in a class of antiviral agents to target this complex for HSV replication inhibition.
- Exhibits antiviral activity against HSV-1 and HSV-2
- Inhibits the viral helicase-primase complex
- Significantly increases survival and reduces mortality in animal models of HSV-1 infection
- Possesses potent and resistance-breaking antiviral efficacy
- Potential for treating life-threatening HSV type 1 and 2 infections, including herpes simplex encephalitis
- Protective when used in combination therapies with Acyclovir against HSV-2
Apexbio Technology LLC Safinamide Mesylate 202825-46-5 10mM (in 1mL DMSO)
Safinamide Mesylate (CAS 202825-46-5) is the mesylate salt form of safinamide a selective and reversible inhibitor of monoamine oxidase B (MAO-B) Safinamide exhibits an IC50 of 98 nM for MAO-B inhibition leading to enhanced dopaminergic transmission by reducing dopamine degradation In addition to MAO-B inhibition safinamide modulates sodium and calcium channels (IC50 8 2 M and 31 5 M respectively) and suppresses glutamate release ( 56 4 M) contributing to its anticonvulsant properties Research applications include the study of Parkinson s disease mechanisms and the investigation of dopaminergic and glutamatergic modulation
Medchemexpress LLC Pergolide mesylate | 66104-23-2 | 99.98% | 410.59 | 25 MG
Pergolide mesylate (Pergolide methanesulfonate) is an Ergoline derivative, and a potent and orally active dopamine D1 and D2 receptors agonist. It can be utilized for research into Parkinson's disease and hyperprolactinaemia.
- Potent and orally active
- Dopamine D1 and D2 receptors agonist
- Utilized for research into Parkinson's disease
- Utilized for research into hyperprolactinaemia
eMolecules 50670-83-2 | 5-Acetamido-2-aminobenzoic acid | Oakwood Chemical | MFCD00060120 | 194.190 | C9H10N2O3 | 95.000 | CC(=O)Nc1ccc(N)c(c1)C(O)=O | 1g | 537718690
5-Acetamido-2-aminobenzoic acid | Oakwood Chemical | 50670-83-2 | MFCD00060120 | 194.190 | C9H10N2O3 | 95.000 | CC(=O)Nc1ccc(N)c(c1)C(O)=O | 1g | 537718690
Chemscene 6-Bromo-2 2 -bipyridyl | 25g | CS-W004576 | 98% | 10495-73-5 | MFCD01318953 | 235 084 | C10H7BrN2
Chemscene | 6-Bromo-2 2 -bipyridyl | 25g | CS-W004576 | 98% | 10495-73-5 | MFCD01318953 | 235 084 | C10H7BrN2